Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
[The role of vitamin D in multiple sclerosis].
High incidence and increasing prevalence of multiple sclerosis in British Columbia, Canada: findings from over two decades (1991-2010).
Electrodiagnostic criteria for Guillain-Barrè syndrome: A critical revision and the need for an update.
Interferon-γ Activates Nuclear Factor-κ B in Oligodendrocytes through a Process Mediated by the Unfolded Protein Response.
Short-term evolution of spinal cord damage in multiple sclerosis: a diffusion tensor MRI study.
Patients' perspectives on quality of mental health care for people with MS.
Body mass index and waist circumference in persons aging with muscular dystrophy, multiple sclerosis, post-polio syndrome, and spinal cord injury.
Paradoxical inflammation induced by anti-TNF agents in patients with IBD.
A novel monoclonal antibody against the C-terminal region of aquaporin-4.
Perception of affective prosody in patients at an early stage of relapsing-remitting multiple sclerosis.
Structural equation modeling of factors contributing to quality of life in Japanese patients with multiple sclerosis.
The T-cell immunoglobulin and mucin domain (Tim) gene family in asthma, allergy, and autoimmunity.
Work capacity and health-related quality of life among individuals with multiple sclerosis reduced by fatigue: a cross-sectional study.
Endovascular diagnosis and management of chronic cerebrospinal venous insufficiency: retrospective analysis of 30-day morbidity and mortality in 95 consecutive patients.
Safety and Tolerability of Fingolimod in Latin American Patients with Relapsing-Remitting Multiple Sclerosis: The Open-Label FIRST LATAM Study.
Self-rating makes the difference: Identifying palliative care needs of patients feeling severely affected by multiple sclerosis.
To be 17 again--anti-interleukin-17 treatment for psoriasis.
Unfavorable outcomes during treatment of multiple sclerosis with high doses of vitamin D.
Update on Disease-Modifying Treatments for Multiple Sclerosis.
Establishment and characterization of an optimized mouse model of multiple sclerosis-induced neuropathic pain using behavioral, pharmacologic, histologic and immunohistochemical methods.
Alemtuzumab for the treatment of relapsing-remitting multiple sclerosis.
A selective thyroid hormone β receptor agonist enhances human and rodent oligodendrocyte differentiation.
Metallic gold slows disease progression, reduces cell death and induces astrogliosis while simultaneously increasing stem cell responses in an EAE rat model of multiple sclerosis.
Recommendations for optimal ICD codes to study neurologic conditions: A systematic review.
Symptomatic therapy in multiple sclerosis: the role of cannabinoids in treating spasticity.
Pages
« first
‹ previous
…
339
340
341
342
343
344
345
346
347
…
next ›
last »